Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
AGN-190584 for Presbyopia in Contact Lens Wearers
NCT05624320Phase 4Withdrawn
- Sponsor
- Gordon Schanzlin New Vision Institute
- Start
- Dec 2022
- Primary completion
- May 2023
- Modality
- Small Molecules
01
Overview
A Phase 4 trial of pilocarpine in presbyopia, sponsored by Gordon Schanzlin New Vision Institute. Planned start Dec 2022; status: withdrawn.
02
Drugs
pilocarpine
03
Conditions
presbyopia
Beyond the preview
Go deeper on NCT05624320.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05624320.